source · text/csv
source_1c6d2d10fd574153
sha256 2d7a8faafe32ade7435c640a6e66f20cac79b16b3d1cc37bb82939be42e4f932
by researka:v2 · 2026-06-02 09:18:44.135966+04:00
study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness Use of metformin and survival of patients with high‐grade glioma,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Association Between Preadmission Metformin Use and Outcomes in Intensive Care Unit Patients With Sepsis and Type 2 Diabetes: A Cohort Study,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Metformin in Patients With COVID-19: A Systematic Review and Meta-Analysis,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level "Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
metadata
{
"researka_object_type": "publication_sidecar",
"researka_publication_id": "ab40c73a-dca5-4102-8b82-441a90f13b37",
"researka_submission_id": "e2c7fc40-0c68-47c0-805b-b56bc538ee9f",
"sidecar_name": "evidence_table.csv",
"sidecar_url": "https://api.researka.org/publications/ab40c73a-dca5-4102-8b82-441a90f13b37/sidecars/evidence_table.csv"
}